C-Further Unveils First Therapeutic Programmes Dedicated to Paediatric Oncology March 10, 2026 C-Further to advance its first two bespoke paediatric cancer therapeutics in collaboration with leading global academic and industry investigators Selected programmes to potentially address multiple children’s cancers including Ewing sarcoma, bone sarcoma, medulloblastoma and acute myeloid leukaemia Additional C-Further programmes to be announced in 2026
Nextdoor Launches AI-Powered Click Optimisation to Propel Hyperlocal Advertising March 10, 2026 New advanced tools boost ROI for advertisers, including Verisure, delivering four times more clicks for the same budget
Amentum-led Joint Venture selected for $112 Million Clean-up at Four European Nuclear Research Sites March 10, 2026 A joint venture led by Amentum (NYSE: AMTM) has won a new framework contract as the lead decommissioning and waste management contractor for nuclear research sites in four European countries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260310491705/en/ Under the $112 million (€95.7 million) contract, awarded by the European Commission Joint Research [...]
VIPR Announces Strategic Engagement with Aon to Transform Delegated Authority Operations March 10, 2026 Multi-year engagement to deliver intelligent automation and operational clarity across global reinsurance platform
Operio Group Named Distributor for Schaefer Technologies in the United Kingdom and European Union March 9, 2026 Operio Group has signed a distribution agreement with Schaefer Technologies, a manufacturer of semi-automatic encapsulation equipment. Operio Group, a holding company building a global group of brands serving the solid dose manufacturing industry, will be the official distributor of Schaefer Technologies’ products in the United Kingdom and the European Union. Schaefer Technologies develops semi-automatic capsule [...]
Prothena Announces Achievement of $50 Million Clinical Milestone Payment from Novo Nordisk Related to Ongoing Phase 3 Clinical Trial for Coramitug (Formerly PRX004) in ATTR Amyloidosis with Cardiomyopathy March 9, 2026 Coramitug is a potential first-in-class amyloid depleter antibody for the treatment of ATTR amyloidosis with cardiomyopathy1-3 Prothena has now earned $150 million to date of the $1.2 billion total eligible milestone payments from Novo Nordisk
ResultsCX Appoints Gautam Thakkar as Chief Executive Officer March 9, 2026 ResultsCX, a provider of Customer Experience Management (CXM) services to leading global companies including Fortune 100 and FTSE 250 organizations, today announced the appointment of Gautam Thakkar as Chief Executive Officer. Thakkar will also join the company’s Board of Directors. Thakkar brings more than three decades of global leadership experience in business services, with a [...]
InterSystems Appoints Former NHS and Mass General Leader Dr. Tim Ferris as Vice President, Healthcare Practice March 9, 2026 InterSystems, a creative data technology provider powering more than one billion health records globally, today announced the appointment of Tim Ferris, M.D., as Vice President, Healthcare Practice. The announcement comes as healthcare leaders gather for the 2026 HIMSS Global Health Conference & Exhibition. In this role, Dr. Ferris will leverage his comprehensive view of the [...]
ABB Robotics Partners with NVIDIA to Deliver Industrial-Grade Physical AI at Scale March 9, 2026 ABB Robotics integrates NVIDIA Omniverse libraries into RobotStudio® to deliver physical AI for industry, closing the gap from virtual training to real-world deployment with up to 99% accuracy New RobotStudio HyperReality, available second half of 2026, will fundamentally change how quickly and reliably manufacturers can scale production, reducing costs by up to 40% and accelerating time-to-market by 50% Full range and breadth of industrial applications, with real-world pilot being conducted by Foxconn in consumer electronics assembly At NVIDIA GTC, the robotic workforce company WORKR will showcase how it’s using the solution to help manufacturers across the U.S. addressing critical labor shortages
Dealings in Securities by Executive Directors of AngloGold Ashanti plc March 9, 2026 AngloGold Ashanti plc (the “Company”) (NYSE: AU; JSE: ANG) announces that Executive Directors, Alberto Calderon and Gillian Doran, have dealt in securities of the Company. Name of Executive Director Alberto Calderon Name of Company AngloGold Ashanti plc Date of transaction 6 March 2026 Nature of transaction Off-market receipt of vested shares under the 2023 Deferred [...]